Lasting response to ovariectomy in severe intractable premenstrual syndrome
- PMID: 2301523
- DOI: 10.1016/0002-9378(90)90830-z
Lasting response to ovariectomy in severe intractable premenstrual syndrome
Abstract
A total of 14 women with severe premenstrual syndrome unresponsive to conservative medical therapy were treated with danazol in doses sufficient to suppress cyclic ovarian steroidogenesis. In each case medical ovarian suppression resulted in complete relief from symptoms. For ongoing symptom relief, each woman elected to undergo bilateral ovariectomy and concomitant hysterectomy. Both medical ovarian suppression and ovariectomy with low-dose conjugated estrogen therapy afforded lasting relief from cyclic symptoms of premenstrual syndrome and a corresponding improvement in overall quality of life. We conclude that cyclic ovarian steroidogenesis is a powerful determinant for the expression of premenstrual symptomatology. Ovariectomy with low-dose estrogen replacement is an effective alternative for the woman with debilitating premenstrual syndrome who does not respond to conventional interventions.
Similar articles
-
The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome.Am J Obstet Gynecol. 1990 Jan;162(1):105-9. doi: 10.1016/0002-9378(90)90831-q. Am J Obstet Gynecol. 1990. PMID: 2301479
-
Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):18-23. doi: 10.1016/s0002-9378(99)70142-0. Am J Obstet Gynecol. 1999. PMID: 9914571 Clinical Trial.
-
When should surgical treatment be considered for premenstrual dysphoric disorder?Menopause Int. 2012 Jun;18(2):77-81. doi: 10.1258/mi.2012.012009. Menopause Int. 2012. PMID: 22611227 Review.
-
Can one induce premenstrual symptomatology in women with prior hysterectomy and bilateral oophorectomy?J Psychosom Obstet Gynaecol. 1996 Mar;17(1):21-8. doi: 10.3109/01674829609025660. J Psychosom Obstet Gynaecol. 1996. PMID: 8860883
-
Indications for drug therapy in premenstrual syndrome patients.J Reprod Med. 1987 Jun;32(6):449-52. J Reprod Med. 1987. PMID: 2956417 Review.
Cited by
-
Global burden and trends in female premenstrual syndrome study during 1990-2019.Arch Womens Ment Health. 2024 Jun;27(3):369-382. doi: 10.1007/s00737-024-01426-4. Epub 2024 Jan 27. Arch Womens Ment Health. 2024. PMID: 38280031
-
Resident intruder paradigm-induced PMDD rat model of premenstrual irritability: behavioral phenotypes, drug intervention, and biomarkers.Aging (Albany NY). 2022 Nov 27;14(22):9210-9220. doi: 10.18632/aging.204402. Epub 2022 Nov 27. Aging (Albany NY). 2022. PMID: 36441533 Free PMC article.
-
Full Remission of Long-Term Premenstrual Dysphoric Disorder-Like Symptoms Following Resection of a Pituitary Adenoma: Case Report.Am J Case Rep. 2020 Aug 8;21:e922797. doi: 10.12659/AJCR.922797. Am J Case Rep. 2020. PMID: 32769963 Free PMC article.
-
Eating disorders in premenstrual dysphoric disorder: a neuroendocrinological pathway to the pathogenesis and treatment of binge eating.J Eat Disord. 2018 Oct 25;6:35. doi: 10.1186/s40337-018-0222-2. eCollection 2018. J Eat Disord. 2018. PMID: 30386599 Free PMC article.
-
Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.Am J Psychiatry. 2017 Oct 1;174(10):980-989. doi: 10.1176/appi.ajp.2017.16101113. Epub 2017 Apr 21. Am J Psychiatry. 2017. PMID: 28427285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
